NORDIC BIOSCIENCE HOLDING A/S: Financial statements 2012
CVR: 30511271
Source: annual report 2012, Danish Business Authority
01/01/2012 – 31/12/2012
NORDIC BIOSCIENCE HOLDING A/S (CVR 30511271) has filed annual accounts for 2012. In 2012, the company reported a gross profit of DKK -49,000 and a net result of DKK -63,475,000. Equity in the 2012 report amounted to DKK 217,493,000. The solvency ratio was 94.6%.
- Gross Profit
- DKK -49,000
- Profit/Loss
- DKK -63,475,000
- Equity
- DKK 217,493,000
- Total Assets
- DKK 230,020,000
Official annual report
Keep an eye on NORDIC BIOSCIENCE HOLDING A/S
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2012
As of March 8, 2012, David H Mac Callum has left the board of directors of NORDIC BIOSCIENCE HOLDING A/S.
About NORDIC BIOSCIENCE HOLDING A/S
NORDIC BIOSCIENCE HOLDING A/S is a Danish company of the type Aktieselskab based in Herlev, founded in 2007. The company is registered under the industry Ikke-finansielle holdingselskaber. The management consists of Morten Asser Karsdal. The board consists of Claus Henrik Christiansen (chair), Steffen Kragh, Henrik Bernt Sanders and Kugan Sathiyanandarajah. The company is owned by Nordic Life Science Consulting ApS, Romarine ApS and KKR Precision Aggregator L.P.. The company has 1 employee (2025). In 2025, the company reported revenue of DKK 426,285,000 and a net result of DKK 54,532,000 compared with DKK 170,813,000 the year before. Equity in the 2025 report amounted to DKK 71,184,000.